000 01325 a2200397 4500
005 20250513084848.0
264 0 _c19960312
008 199603s 0 0 ita d
022 _a1121-7138
040 _aNLM
_beng
_cNLM
100 1 _aEdwards, J R
245 0 0 _a[Preclinical evaluation of meropenem, a new parenteral carbapenem].
_h[electronic resource]
260 _bThe new microbiologica
_cOct 1995
300 _a19S-31S p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBacteria, Aerobic
_xdrug effects
650 0 4 _aBacteria, Anaerobic
_xdrug effects
650 0 4 _aBacterial Infections
_xdrug therapy
650 0 4 _aDipeptidases
_xmetabolism
650 0 4 _aGram-Negative Bacteria
_xdrug effects
650 0 4 _aGram-Positive Bacteria
_xdrug effects
650 0 4 _aGuinea Pigs
650 0 4 _aHumans
650 0 4 _aImipenem
_xpharmacology
650 0 4 _aMeropenem
650 0 4 _aMice
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMolecular Structure
650 0 4 _aPenicillin Resistance
_xgenetics
650 0 4 _aPenicillins
_xpharmacology
650 0 4 _aThienamycins
_xpharmacology
650 0 4 _abeta-Lactamases
_xmetabolism
773 0 _tThe new microbiologica
_gvol. 18 Suppl
_gp. 19S-31S
999 _c8573987
_d8573987